Ovid Therapeutics Inc (OVID) — Long-term Investment Intensity
Ovid Therapeutics Inc (OVID) has a Long-term Investment Intensity of 41.6% as of December 2025. Long-term investments of $62.77 Million represent 41.6% of total assets of $150.93 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Ovid Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ovid Therapeutics Inc Long-term Investment Intensity (2021–2025)
This chart shows how Ovid Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 41.6%, reflecting long-term investments of $62.77 Million against total assets of $150.93 Million USD. Explore Ovid Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Ovid Therapeutics Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Ovid Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Ovid Therapeutics Inc market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 41.6% | $62.77 Million | $150.93 Million | ▲ +18.8 pp |
| 2024 | 22.8% | $20.97 Million | $92.17 Million | ▲ +10.5 pp |
| 2023 | 12.2% | $17.63 Million | $144.03 Million | ▲ +8.6 pp |
| 2022 | 3.6% | $5.62 Million | $155.27 Million | ▲ +2.8 pp |
| 2021 | 0.8% | $1.63 Million | $194.54 Million | — |